Related references
Note: Only part of the references are listed.Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia A Randomized Clinical Trial
Steven Y. C. Tong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia
S. Weis et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States
Athena P. Kourtis et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Epidemiology and Outcome Determinants of Staphylococcus aureus Bacteremia Revisited: A Population-Based Study
John C. Lam et al.
INFECTION (2019)
Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis A Diagnostic Study
Matthew P. Cheng et al.
ANNALS OF INTERNAL MEDICINE (2019)
Impact of β-Lactam and Daptomycin Combination Therapy on Clinical Outcomes in Methicillin-susceptible Staphylococcus aureus Bacteremia: A Propensity Score-matched Analysis
Sara Grillo et al.
CLINICAL INFECTIOUS DISEASES (2019)
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
Guy E. Thwaites et al.
LANCET (2018)
Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial
Matthew P. Cheng et al.
TRIALS (2018)
Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia A Randomized Clinical Trial
Thomas L. Holland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition
P. N. A. Harris et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Comparative Effectiveness of Cefazolin Versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study
Jennifer S. McDanel et al.
CLINICAL INFECTIOUS DISEASES (2017)
Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial
Joshua S. Davis et al.
CLINICAL INFECTIOUS DISEASES (2016)
Reversion From Methicillin Susceptibility to Methicillin Resistance in Staphylococcus aureus During Treatment of Bacteremia
Megan K. Proulx et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Back to the Future: Penicillin-Susceptible Staphylococcus aureus
Matthew P. Cheng et al.
AMERICAN JOURNAL OF MEDICINE (2016)
Risk factors for long-term mortality of Staphylococcus aureus bacteremia
D. Yahav et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2016)
CAMERA2-combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial
Steven Y. C. Tong et al.
TRIALS (2016)
Predictive Factors for Metastatic Infection in Patients With Bacteremia Caused by Methicillin-Sensitive Staphylococcus aureus
Tetsuya Horino et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2015)
Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study
Anthony D. Bai et al.
CLINICAL INFECTIOUS DISEASES (2015)
Combination Antibiotic Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections
J. S. Davis et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Clinical Management of Staphylococcus aureus Bacteremia A Review
Thomas L. Holland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Stable incidence and continued improvement in short term mortality of Staphylococcus aureus bacteraemia between 1995 and 2008
Niels Mejer et al.
BMC INFECTIOUS DISEASES (2012)
Predictors of Mortality in Staphylococcus aureus Bacteremia
Sebastian J. van Hal et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Staphylococcus aureus bloodstream infections:: Risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006
Kevin B. Laupland et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000
T. Benfield et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Management of persistent Bacteremia caused by methicillin-resistant Staphylococcus aureus: A survey of infectious diseases consultants
Jeffrey C. Hageman et al.
CLINICAL INFECTIOUS DISEASES (2006)
Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: Comparison with cationic antimicrobial peptides and lipopeptides
Suzana K. Straus et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and enterococci by FIC index and timed-kill curves
DR Snydman et al.
JOURNAL OF CHEMOTHERAPY (2005)
Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections
JN Steenbergen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Synergy of daptomycin with oxacillin and other β-lactams against methicillin-resistant Staphylococcus aureus
KH Rand et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Clinical identifiers of complicated Staphylococcus aureus bacteremia
VG Fowler et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials
D Moher et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
